An independent assessment provides the basis for a sound, data-driven investment decision.
To independently assess the commercialisation potential of a patented, enzyme-based technology for enhancing natural fibres, and to establish a solid basis for deciding for or against further investment – in a market environment smaller, more fragmented and more competitive than the original thesis assumed.
The aim was not to confirm Bloomfibre's potential, but to test it with an open mind. Over several months, fibres from different suppliers were compared, processing steps followed onsite, and conversations held with spinning mills, manufacturers and material strategists at leading brands.
The analysis showed that the original positioning no longer held up – the assumed competitive advantage did not survive comparison with the true relevant competitors. At the same time, a new, credible point of differentiation was identified, already backed by initial proof of effectiveness.
This produced a structured decision framework with three clearly defined options – repositioning, a time-boxed, measurable test, or an orderly wind-down while retaining the patent rights. A disciplined, deadline-driven test with clear success criteria creates decision clarity before further capital is committed.
